REDWOOD CITY, Calif., Nov. 27 /PRNewswire-FirstCall/ -- FoxHollow Technologies , which manufactures and markets minimally invasive devices for the treatment of peripheral and coronary artery disease, is scheduled to participate in the Piper Jaffray 18th Annual Health care Conference on Thursday, November 30, 2006, in New York.
John Simpson, chief executive officer, will provide an update on the company at 12:30 p.m. Eastern Time (9:30 a.m. Pacific Time).
A live audio webcast of the presentation will be available via the Internet at http://investor.foxhollowtech.com and will be available for replay for approximately three months.
About FoxHollow Technologies
FoxHollow Technologies, Inc., develops and markets minimally invasive devices for the removal of plaque and thrombus for the treatment of peripheral artery disease (PAD). An estimated 12 million people in the United States are thought to suffer from PAD, with 2.5 million patients currently diagnosed. PAD results from plaque that accumulates in the arteries and blocks blood flow in the legs. These blockages can result in severe pain for patients and very limited physical mobility. The company’s SilverHawk System is a minimally invasive method of removing the obstructive plaque and restoring blood flow to the legs and feet. The company’s Rinspirator thrombectomy system, acquired in September 2006, removes thrombus, or blood clots, from occluded arteries in patients suffering from PAD or CAD. For more information, please visit our website at http://www.foxhollowtech.com .
Contacts Investor Relations: Matt Ferguson Chief Financial Officer 650-421-8449 investorrelations@foxhollowtech.com Media Relations: Robin Gaffney 650-421-8614 rgaffney@foxhollowtech.com
FoxHollow Technologies
CONTACT: Matt Ferguson, Chief Financial Officer, +1-650-421-8449, orinvestorrelations@foxhollowtech.com, or media, Robin Gaffney,+1-650-421-8614, or rgaffney@foxhollowtech.com, both of FoxHollowTechnologies
Web site: http://www.foxhollowtech.com/
